Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03260244 · ClinicalTrials.gov registry record
EnSite Precision Observational Study
A clinical trial of Cardiac Arrhythmia, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,065
- Enrollment target
- 7
- Study locations
NCT03260244 is a study of Cardiac Arrhythmia that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,065 participants, above the 125-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (752% higher). The trial reports 7 study locations across 6 states.
The verdict
NCT03260244, a study of Cardiac Arrhythmia, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,065 participants
- Enrollment target
- 7
- Study locations
Study Summary
This document is a clinical investigation plan (CIP) for the EnSite Precision Observational Study. This clinical study is intended to quantify and characterize the usage of the EnSite Precision™ Cardiac Mapping System (Software version 2.0.1 or higher) in a real-world environment. This study will be conducted in patients who are indicated for a cardiac electrophysiological (EP) mapping and radio frequency ablation procedure using a three-dimensional system.
Conditions Studied
Interventions
- PROCEDURE cardiac mapping and radiofrequency ablation procedure
Study Locations (7)
Arkansas
- Cardiology Associates of North East Arkansas - Jonesboro
- Arkansas Cardiology - Little Rock
Alabama
- Baptist Medical Center Princeton - Birmingham
Florida
- Bethesda Memorial Hospital - Boynton Beach
Missouri
- Barnes-Jewish Hospital - St Louis
Nebraska
- Bryan LGH Medical Center East - Lincoln
Wisconsin
- Aurora Medical Group - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,065 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2020-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03260244
The ClinicalTrials.gov registry entry for NCT03260244 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,065 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 125-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (752% higher). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which cardiac mapping and radiofrequency ablation procedure is the first listed.
NCT03260244 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Arkansas, Alabama, Florida.
Frequently Asked Questions
What is clinical trial NCT03260244 about?
NCT03260244 is a clinical study titled "EnSite Precision Observational Study". This document is a clinical investigation plan (CIP) for the EnSite Precision Observational Study. This clinical study is intended to quantify and characterize the usage of the EnSite Precision™ Cardiac Mapping System (Software version 2.0.1 or higher) in a real-world environment. This study will b...
What is the current status of trial NCT03260244?
This trial is currently completed. The enrollment target is 1,065 participants. The study started on 2017-09-12. Estimated completion is 2020-03-31.
What conditions does trial NCT03260244 study?
This clinical trial studies the following conditions: Cardiac Arrhythmia.
What interventions are being tested in trial NCT03260244?
The interventions under investigation include: cardiac mapping and radiofrequency ablation procedure (PROCEDURE).
Who is sponsoring clinical trial NCT03260244?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03260244 being conducted?
This trial has 7 study locations across Alabama, Arkansas, Florida, Missouri, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrhythmia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
ACTIVE NOT RECRUITING
-
Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II
ACTIVE NOT RECRUITING · NA
-
AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals
COMPLETED · NA
-
Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
COMPLETED · NA
-
Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure
COMPLETED · NA
-
SJM MRI Diagnostic Imaging Registry (IDE)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.